News

• Royalty Pharma Declares Second-Quarter 2021 Dividend
  15:00 - GlobeNewswire
•  
• Adverum Files Definitive Proxy Materials and Mails Letter to Stockholders Detailing Strength of Team and Acceleration Toward Commercialization of ADVM-022
  14:00 - GlobeNewswire
•  
• Oxford Biomedica plc Preliminary results for the year ended 31 December 2020
  13:00 - GlobeNewswire
•  
• Novartis to help Roche make potential COVID drug
  08:53 - TeleTrader
•  
• Immutep Announces European Patent Grant For LAG525 Antibody In Combination Therapy
  04/07/2021 / 14:00 - GlobeNewswire
•  
• Novartis, Artios to develop cancer treatment
  04/07/2021 / 08:21 - TeleTrader
•  
• Appointment of Ben Vertannes as Head of Global Marketing
  03/08/2021 / 08:00 - GlobeNewswire
•  
• Novartis to help CureVac boost vaccine production
  03/04/2021 / 14:25 - TeleTrader
•  
• Novartis Entresto® granted expanded indication in chronic heart failure by FDA
  02/16/2021 / 19:22 - GlobeNewswire
•  
• Novartis signs initial deal to manufacture Pfizer jabs
  01/29/2021 / 13:04 - TeleTrader
•  
• Novartis Sees 6-Figure Savings with Qlik
  01/26/2021 / 14:30 - GlobeNewswire
•  
• Novartis misses estimates with revenue at $12.77B in Q4
  01/26/2021 / 07:07 - TeleTrader
•  
• Immutep Announces Australian Patent Grant For IMP701 Antibody
  11/09/2020 / 14:00 - GlobeNewswire
•  
• McEldrew Young Partner Eric L. Young Named “Lawyer of the Year” for 2020 by the Taxpayers Against Fraud Education Fund
  11/02/2020 / 17:17 - GlobeNewswire
•  
• Novartis' EPS surpasses estimates at $1.52 in Q3
  10/27/2020 / 07:06 - TeleTrader